Invex Therapeutics Ltd (ASX:IXC)

Invex Therapeutics Revenue

Invex Therapeutics had revenue of 1.21M AUD in the twelve months ending December 31, 2024, up 9,856.93% year-over-year. In the fiscal year ending June 30, 2024, Invex Therapeutics had annual revenue of 1.21M with 164.06% growth.

• Revenue: 1.21M
• Revenue Growth: +9,856.93%
• P/S Ratio: 4.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.21M	753.17K	164.06%
Jun 30, 2023	459.09K	276.83K	151.90%
Jun 30, 2022	182.25K	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-